Literature DB >> 22198978

Hospitalization costs for acute ischemic stroke patients treated with intravenous thrombolysis in the United States are substantially higher than medicare payments.

Waleed Brinjikji1, Alejandro A Rabinstein, Harry J Cloft.   

Abstract

BACKGROUND AND
PURPOSE: It is important to know the costs for hospitalization for ischemic stroke patients treated with intravenous thrombolysis so that comparisons can be made with payments to hospitals.
METHODS: Using the National Inpatient Sample, we evaluated hospitalization costs for patients treated with intravenous thrombolysis for acute ischemic stroke in the United States from 2001 to 2008. Cost data were correlated with demographics and clinical outcome.
RESULTS: Intravenous thrombolysis for acute ischemic stroke was received by 63 472 patients; 24 094 patients were younger than age 65 years and 40 780 patients were 65 years or older. Median hospital costs in 2008 dollars were $14 102 (interquartile range, $9987-$20 819) for patients with good outcome, $18 856 (interquartile range, $13 145-$30 423) for patients with severe disability, and $19 129 (interquartile range, $11 966-$30 781) for patients with in-hospital mortality. Average 2008 Medicare payments were $10 098 for intravenous thrombolysis without complication and $13 835 for intravenous thrombolysis with major complication.
CONCLUSIONS: Hospitalization costs for patients treated with intravenous thrombolysis are substantially higher than Medicare payments.

Entities:  

Mesh:

Year:  2011        PMID: 22198978     DOI: 10.1161/STROKEAHA.111.636142

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  18 in total

1.  Capitalism and commodities: my two cents.

Authors:  H J Cloft
Journal:  AJNR Am J Neuroradiol       Date:  2013-03-14       Impact factor: 3.825

2.  Patient Age and the Outcomes after Decompressive Hemicraniectomy for Stroke: A Nationwide Inpatient Sample Analysis.

Authors:  Hormuzdiyar H Dasenbrock; Faith C Robertson; M Ali Aziz-Sultan; Donovan Guittieres; Rose Du; Ian F Dunn; William B Gormley
Journal:  Neurocrit Care       Date:  2016-12       Impact factor: 3.210

3.  Atrial Fibrillation Associated Costs for Stroke Hospitalizations of Medicare Beneficiaries in the Stroke Belt of the United States.

Authors:  Guijing Wang; Xin Tong; Mary G George
Journal:  J Atr Fibrillation       Date:  2013-04

4.  Hospital costs associated with atrial fibrillation for patients with ischemic stroke aged 18-64 years in the United States.

Authors:  Guijing Wang; Heesoo Joo; Xin Tong; Mary G George
Journal:  Stroke       Date:  2015-04-07       Impact factor: 7.914

5.  Discharge Patterns for Ischemic and Hemorrhagic Stroke Patients Going From Acute Care Hospitals to Inpatient and Skilled Nursing Rehabilitation.

Authors:  Ickpyo Hong; Amol Karmarkar; Winston Chan; Yong-Fang Kuo; Trudy Mallinson; Kenneth J Ottenbacher; James S Goodwin; Clark R Andersen; Timothy A Reistetter
Journal:  Am J Phys Med Rehabil       Date:  2018-09       Impact factor: 2.159

6.  Atrial Fibrillation Associated Costs for Stroke Hospitalizations of Medicare Beneficiaries in the Stroke Belt of the United States.

Authors:  Guijing Wang; Xin Tong; Mary G George
Journal:  J Atr Fibrillation       Date:  2013-04-06

7.  Cost-Effectiveness of Patent Foramen Ovale Closure Versus Medical Therapy for Secondary Stroke Prevention.

Authors:  Michelle H Leppert; Sharon N Poisson; John D Carroll; David E Thaler; Chong H Kim; Karen D Orjuela; P Michael Ho; James F Burke; Jonathan D Campbell
Journal:  Stroke       Date:  2018-05-02       Impact factor: 7.914

8.  Economic burden of stroke: a systematic review on post-stroke care.

Authors:  S Rajsic; H Gothe; H H Borba; G Sroczynski; J Vujicic; T Toell; Uwe Siebert
Journal:  Eur J Health Econ       Date:  2018-06-16

9.  Optimizing the Economic Impact of rtPA Use in a Stroke Belt State: The Case of South Carolina.

Authors:  Abby Swanson Kazley; Kit N Simpson; Annie Simpson; Edward Jauch; Robert J Adams
Journal:  Am Health Drug Benefits       Date:  2013-05

Review 10.  The empirical foundations of telemedicine interventions for chronic disease management.

Authors:  Rashid L Bashshur; Gary W Shannon; Brian R Smith; Dale C Alverson; Nina Antoniotti; William G Barsan; Noura Bashshur; Edward M Brown; Molly J Coye; Charles R Doarn; Stewart Ferguson; Jim Grigsby; Elizabeth A Krupinski; Joseph C Kvedar; Jonathan Linkous; Ronald C Merrell; Thomas Nesbitt; Ronald Poropatich; Karen S Rheuban; Jay H Sanders; Andrew R Watson; Ronald S Weinstein; Peter Yellowlees
Journal:  Telemed J E Health       Date:  2014-06-26       Impact factor: 3.536

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.